Pharmaceuticals ROI at Low Point
Industry must use technology to unlock productivity ROI is at a low point in the pharmaceuticals industry, according the Deloitte 2018 report on the industry: R&D returns have declined to 1.9 percent, down from 10.1 percent in 2010—the lowest level in nine years; Returns have been impacted by the growing cost of bringing a drug…